Tiger Brokers

  • Quotes
  • Invest
  • Pricing
  • Rewards
  • Support
  • TigerAI
  • Learn
  • About
  • LOGIN
  • SIGN UP
US StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

Blueprint Medicines

127.96
-0.2500-0.19%
Post-market: 128.230.2700+0.21%17:27 EDT
Volume:4.73M
Turnover:606.03M
Market Cap:8.27B
PE:-52.16
High:128.27
Open:128.18
Low:127.95
Close:128.21
Loading ...
OverviewCompanyNewsFilings

Concept

Hillhouse Capital Holdings-1.73%

Capital Flow

 
Inflow:
 
Outflow:
 
 
 
 
 
 
 
 
 
 
 
 
 
 

News

Barclays Sticks to Their Hold Rating for Blueprint Medicines (BPMC)

TIPRANKS
·
13 Jun

Blueprint Medicines announces data reinforcing sustained efficacy of AYVAKIT

TIPRANKS
·
13 Jun

Blueprint Medicines Unveils Promising Long-Term Data for AYVAKIT® in Systemic Mastocytosis at 2025 EHA and EAACI Congresses

Reuters
·
13 Jun

Blueprint Medicines Announces Data Reinforcing Sustained Clinical Efficacy and Well-Tolerated Safety Profile of Long-Term Ayvakit®/Ayvakyt® (Avapritinib) Treatment at 2025 Eha and Eaaci Congresses

THOMSON REUTERS
·
13 Jun

Analyst Rate

Hold
Buy
21.05%
Hold
78.95%
Sell
0.00%

Corporate Actions

Financial Report Announcement
May 01, 2025 Pre-Market
Financial Report Announcement
Feb 13, 2025 Pre-Market
Financial Report Announcement
Oct 30, 2024 Pre-Market
Financial Report Announcement
Aug 01, 2024 Pre-Market
Financial Report Announcement
May 02, 2024 Pre-Market

Dividend History

no data

No relevant data is available

Valuation Analysis

-53.24
Current
-10.82
Sector Average
5.48%
Historical Percentile
P/E[TTM]
+1 STD
Average
-1 STD
Current
-53.24
Maximum
20.68
+1 STD
12.41
Minimum
-90.67
-1 STD
-34.05
Average
-10.82

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10
     
     
     
     
Company Name:
Tiger Fintech (Singapore) Pte. Ltd.
Email Address:
uservice@ttm.financial
User Agreement|Privacy Policy

Copyright © Tiger Fintech (Singapore) Pte. Ltd.

Product offerings in different jurisdictions may vary.

Information contained on this website is general in nature and does not take into account of your investment objectives, financial situation and specific needs. It should not be regarded as an offer to sell, asolicitation to buy, a recommendation or endorsement for any financial product, nor does it constitute an investment forecast, investment return commitments, investment suggestions or other practical operating opinions. Information contained on this website is for reference only and past performance should not be construed as future performance. Investment involves risks. Before you make an investment decision, you should carefully judge and screen whether the information contained on this website is appropriate for your needs, goals and circumstances.

We strive but cannot guarantee the accuracy, completeness, reliability and timeliness of all information on this website, and we are not responsible for any losses caused by the use of or reliance on relevant information.

The products and services offered on the website are subject to applicable laws, regulations and relevant agreements. Please carefully read and agree to the agreements before using our products and services.